A Multidisciplinary Approach to CAR T-cell Therapy for Adult Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia - Episode 4
CAR T-Cell Therapy for B-ALL: Roles Within the Multidisciplinary Care Team
Experts discuss their distinct roles in patient eligibility, management, and follow-up for chimeric antigen receptor (CAR) T-cell therapy treatment in adult patients with precursor B-cell acute lymphoblastic leukemia (B-ALL), focusing on assessment, treatment planning, and ongoing care.
Video Player is loading.
Video content above is prompted by the following:
Please briefly describe your distinct roles with patient eligibility for CAR T-cell therapy treatment, management, and follow-up in adult patients with precursor B-ALL.